SCHEMBL9680433

SCHEMBL9680433

Cc1ccc(C2CCC(C(=O)O)CC2)cc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
PDE4A P27815 2/20 0.51
PDE4B Q07343 2/20 0.51
PDE4C Q08493 2/20 0.51
PDE4D Q08499 2/20 0.51
AKR1C3 P42330 1/20 0.46
AKR1C1 Q04828 1/20 0.46
DGAT1 O75907 1/20 0.44
SOAT1 P35610 1/20 0.44
GAA P10253 3/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
ACMSD Q8TDX5 2/20 0.39
S1PR5 Q9H228 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NOTUM Q6P988 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2884802 0.83 HTR2C (0.46) ALDH1A1
SCHEMBL9442414 0.80 NPC1 (0.66) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL9442430 0.80 NPC1 (0.66) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL1709747 0.80 GAA (0.48) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL19729104 0.79 NPC1 (0.51) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL3278479 0.77 NPC1 (0.66) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL9681025 0.76 NPC1 (0.56) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL8939442 0.76 NPC1 (0.56) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL8939445 0.76 NPC1 (0.56) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL17877760 0.75 CETP (0.47) NPC1RAB9APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175319-A Antiprotozoa agent, useful for treating malaria, theileriosis, coccidiosis and prophylaxix BURROUGHS WELLCOME CO. (US) 1992-12-29 US disclosed
US-5053432-A Antiprotozoa agents; treatment of malaria BURROUGHS WELLCOME CO. (US) 1991-10-01 US disclosed
EP-0123238-B1 NAPHTHOQUINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1987-06-10 EP disclosed
EP-0123238-A2 Naphthoquinone derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1984-10-31 EP disclosed